Clinical trials are crucial to furthering cancer research and introducing new therapies. The session "Clinical Trials" highlights the design, conduct, and relevance of clinical studies investigating new therapies, drugs, and combination regimens in oncology.".
Clinical trials are carried out in phases, ranging from initial safety evaluations to large-scale efficacy and long-term follow-up assessments. They yield essential information on new therapies, aid in identifying the patient populations who gain most benefit, and set standards of care. This session examines several trial designs, such as randomized controlled trials, adaptive trials, and basket or umbrella studies, which are becoming more common for treating certain genetic mutations or cancer subtypes.
Participants will be informed of ethical considerations, patient recruitment, informed consent, and regulatory requirements that ensure that trials are performed safely and efficiently. The session emphasizes biomarkers, imaging, and molecular profiling in tailoring trial participation and enhancing treatment accuracy.
Participants will learn about current clinical studies, new treatments under investigation, and how to implement trial results into clinical practice. This session highlights the value of clinical trials in taking the science of cancer research and applying it to cancer care for patients and shaping the future of oncology.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
